| | | |   | | | | By Nicholas Florko and Rachel Cohrs Ruby Wallau for STAT The pharma giant AbbVie spent nearly $4 million on lobbying in the first three months of 2022 — more than any other pharma company. Read More | | By Helen Branswell Casey Shenery for STAT If we want to prevent mild Covid-19 infections, we're going to need vaccines that protect us where infections start. Read More | | By Damian Garde and Meg Tirrell and Adam Feuerstein This episode, STAT's Helen Branswell joins us to explain the medical mystery of hepatitis appearing worldwide in young children. Read More | | Sponsor content by REGULATORY AFFAIRS PROFESSIONALS SOCIETY (RAPS) Do you need to understand the practical applications of rapidly changing regulatory requirements? Stay informed about new and changing regulations and their implications for bringing drug products to market with a Regulatory Affairs Certificate in pharmaceuticals from RAPS. You'll build a solid foundation of the latest knowledge and learn how to navigate the rapidly evolving regulatory landscape through a series of self-paced online courses. The curriculum features four core courses and five electives spanning the topical areas of pharmaceuticals, quality, clinical, biologics, and the regulatory profession. Learn more. | | By Bob Herman Adobe Former top Medicare official Sean Cavanaugh said Medicare Advantage’s coding industry offers “no benefit to society.” Read More | | By Brian Wallach and Mike Braun Adobe The Promising Pathway Act, crafted with patient input, gives people with life-threatening illnesses timely access to innovative treatments. Read More | |
No comments